D-0363-2023 Class III Terminated

Recalled by SCA Pharmaceuticals — Windsor, CT

FDA drug recall D-0363-2023 was initiated by SCA Pharmaceuticals on Feb 24, 2023 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated Jun 21, 2023). Affected quantity: 2125 syringes.

Recall details

Product Type
Drugs
Report Date
Mar 8, 2023
Initiation Date
Feb 24, 2023
Termination Date
Jun 21, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2125 syringes

Product description

Fentanyl 1,500 mcg/30 mL syringe, Injection for Intravenous Use, Concentration = 50 mcg/mL, Preservative Free, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor CT 06095, NDC# 70004-0200-16.

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide in the US.

Code information

Lot # 1222043351, exp. date 03/29/2023 1222043387, exp. date 04/05/2023 1222043352, exp. date 04/05/2023 1222043463, exp. date 04/06/2023 1223043922, exp. date 05/04/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0363-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0363-2023. Report a data issue: hello@regdatalab.com.